FREE WEBINAR: Advancing IVIVC-based understanding of Monoclonal Antibody Subcutaneous Bioavailability

Hamsini Dhoolypala at Amgen focuses this talk on in vitro-in vivo correlations and developing new subcutaneous therapies with good PK performance for patients, as well as the collaborative opportunities for industry.

Hamsini Dhoolypala, PhD

Hamsini Dhoolypala, PhD

Senior Associate Scientist

Amgen

2021 Global Drug Bioavailability Enhancement Summit

(Nov 3 - 4, 2021)

 

Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2021 Global Drug Bioavailability Enhancement Virtual Summit this November.

Join 100's of leading drug delivery, formulation and development experts and hear 25+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save over 10% on attendance registration before October 30th, 2021 (Only $449). Likewise, have a platform technology you would like to explore showcasing to the wider audience this November? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time - Only $299)

Pin It on Pinterest

Share This